F-Prime Capital Partners Life Sciences Fund VIII Overview
F-Prime Capital Partners Life Sciences Fund VIII General Information
Description
F-Prime Capital Partners Life Sciences Fund VIII is an early-stage venture capital fund managed by F-Prime Capital. The fund is located in Cambridge, Massachusetts.
Contact Information
Fund Manager's Location
- 1 Main Street
- 13th Floor
- Cambridge, MA 02142
- United States
F-Prime Capital Partners Life Sciences Fund VIII Investments (9)
F-Prime Capital Partners Life Sciences Fund VIII has made a total of 9 investments. Its most recent deal was a with Dinari for . The deal was made on 01-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Dinari | 01-May-2025 | Financial Software | Generating Revenue | |||
| Beads | 26-Dec-2024 | Elder and Disabled Care | Generating Revenue | |||
| Laurus Bio | 06-Dec-2024 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| Solv Protocol | 14-Oct-2024 | Other Financial Services | Generating Revenue | |||
| OXIO | 03-Oct-2024 | Business/Productivity Software | Generating Revenue | |||
| Kintsu (Financial Services) | 15-Apr-2024 | Other Financial Services | Generating Revenue | |||
| Asymmetry Finance | 01-Mar-2024 | Other Financial Services | Startup | |||
| AlphaGen (Drug Discovery) | 18-Oct-2023 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| CLST | 27-Jul-2022 | Seed Round | Financial Software | Generating Revenue |
F-Prime Capital Partners Life Sciences Fund VIII Investment Strategy
F-Prime Capital Partners Life Sciences Fund VIII Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
F-Prime Capital Partners Life Sciences Fund VIII Benchmark (113)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| BITKRAFT Ventures Fund III | |||||
| Norwest Venture Partners XVII | |||||
| Brightmind Ventures I | |||||
| venBio Global Strategic Fund V | |||||
| Altimeter Venture Partners Fund VII | 31-Mar-2026 | ||||
| Matrix Partners XII | |||||
| A-Star Capital Fund II | |||||
| Nexus Ventures VII | |||||
| Thrive Capital Partners Opportunity Fund | 31-Mar-2026 | ||||
| 8VC Fund V |
F-Prime Capital Partners Life Sciences Fund VIII FAQs
-
What is F-Prime Capital Partners Life Sciences Fund VIII?
F-Prime Capital Partners Life Sciences Fund VIII is an early-stage venture capital fund managed by F-Prime Capital.
-
Who manages F-Prime Capital Partners Life Sciences Fund VIII?
F-Prime Capital Partners Life Sciences Fund VIII is managed by F-Prime.
-
Where is F-Prime Capital Partners Life Sciences Fund VIII domiciled?
F-Prime Capital Partners Life Sciences Fund VIII is domiciled in United States: Delaware.
-
What is F-Prime Capital Partners Life Sciences Fund VIII's size?
F-Prime Capital Partners Life Sciences Fund VIII has a size of $500M.
-
What type of fund is F-Prime Capital Partners Life Sciences Fund VIII?
The fund type of F-Prime Capital Partners Life Sciences Fund VIII is Venture.
-
What is the status of F-Prime Capital Partners Life Sciences Fund VIII?
F-Prime Capital Partners Life Sciences Fund VIII is closed.
-
What has F-Prime Capital Partners Life Sciences Fund VIII invested in?
F-Prime Capital Partners Life Sciences Fund VIII has made numerous investments in companies like Dinari, Beads, and Laurus Bio within the Financial Software, Elder and Disabled Care, and Pharmaceuticals and Biotechnology industries.
-
What has F-Prime Capital Partners Life Sciences Fund VIII invested in recently?
F-Prime Capital Partners Life Sciences Fund VIII's latest investment was on 01-May-2025 in Dinari, a company within the Financial Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process